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trial septal perforation (ASP) is a known complication
after percutaneous transvenous mitral commissurotomy
(PTMC), although it usually spontaneously heals. In
cases in which ASP persists, the shunting is predomi-
nantly left to right, and rarely does the shunting reverse to cause clin-
ical cyanosis.
Clinical Summary
A 49-year-old woman with a history of longstanding rheumatic
heart disease presented with breathlessness and cyanosis, as well
as bilateral lower limb swelling, for 2 weeks. She had undergone
closed mitral valvotomy 26 years ago and subsequent PTMC twice
14 and 4 years ago, respectively. Other significant medical histories
are atrial fibrillation and diabetes mellitus. Recent transthoracic
echocardiography (TTE) 1 year ago showed moderate mitral steno-
sis (MS) with a mitral valve area of 1.3 cm2, mild mitral regurgita-
tion (MR), severe tricuspid regurgitation (TR) with a pulmonary
artery systolic pressure of 38 mmHg, and a small atrial septal defect
with left-to-right shunt, which was already shown on TTE 4 years
ago after the second PTMC. Ejection fraction was 55%. She had
mild congestive cardiac failure (CCF) with multiple hospital admis-
sions within the last few months.
She presented this admission with exacerbation of breathlessness
and was found to be in CCF. She was centrally cyanosed, and oxy-
gen saturation on room air was 80% to 86%. TTE revealed right-to-
left shunt through an ASP of 0.7 cm in diameter, severe MS, trivial
MR, and severe TR with a dilated annulus (Figure 1).
Right heart study showed a mean right atrial pressure of 27 mm
Hg and a pulmonary capillary wedge pressure of 22 mmHg. Pulmo-
nary artery systolic pressure was 51 mm Hg. The oximetric sam-
pling showed 72% oxygen saturation in the left ventricle.
The patient improved with diuresis and subsequently agreed to
surgical intervention.
Atrial septal repair with mitral valve replacement and tricuspid
valve repair was performed with median sternotomy. On sternot-
omy, the right atrium was found to be enlarged and tense. Central
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tuted routinely, with aortic and bicaval cannulation. An ASP was
confirmed in the central part of the interatrial septum. The mitral
valve was exposed through a transseptal approach by enlarging
the ASP; the valve and annulus were noted to be heavily calcified,
with severe subvalvar involvement. The mitral valve was then re-
placed with a 29-mm Mosaic porcine bioprosthetic valve (Med-
tronic, Inc, Minneapolis, Minn). The interatrial septum was
repaired. The tricuspid valve was then repaired with a 26-mm Ed-
wardsMC3 annuloplasty ring (Edwards LifeSciences, Irvine, Calif).
Postoperative TTE showed no residual shunt between the right
and left atria. There was satisfactory bioprosthetic valve function
with no MR, a pressure gradient of 4 mm Hg, and mild-to-moderate
TR. Postoperative recovery was uncomplicated, and the patient was
discharged on the 11th postoperative day.
Discussion
Inoue and colleagues1 reported PTMC in 1984 using an interatrial
septal puncture. ASP is a well-known but rare complication of
PTMC. Ishikura and associates2 reported that 15.2% of patients after
PTMCwere found to have an ASP 1 day after the procedure on TTE,
and 4.3% of these persisted more than 1 year. However, none of
these shunts were clinically significant. They were also normally
left-to-right shunts and did not cause cyanosis. On rare occasions,
however, the combination of MS, TR, and PHT can result in an
right-to-left shunt, leading to cyanosis.3
Prior admissions for CCF showed a constant left-to-right shunt,
which was noted on serial echocardiographic analysis for the past 4
Figure 1. Preoperative transthoracic echocardiogram showing
severe tricuspid regurgitation and right-to-left shunt.arch 2008
Brief Communicationsyears. The patient had cyanosis on this admission in conjunction
with recurrent CCF. TTE then revealed shunt reversal, explaining
the onset of cyanosis.
One possible cause of shunt reversal was that the severe TR was
directing the flow into the ASP, causing shunting to the left atrium as
the severity increased. Another possibility was the change in the
pressure gradient between the left and right atria: the pressure in
the right atrium was 5 mm Hg higher than the pulmonary capillary
wedge pressure at the time of the right heart study. This might be due
to the combination of worsening pulmonary hypertension and TR.
A reversal of shunt needs to be considered when there is a sudden
onset of cyanosis during the follow-up after PTMC for MS. In suchSuccessful lysis of an aortic prosthe
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lthough valve thrombosis is infrequent, patients with
prosthetic valves have a lifelong risk of this complica-
tion. Because operative mortality can be significant,
thrombolysis has emerged as an alternative therapy
for high-risk surgical patients.1-3 Recent reports have included the
use of tissue-type plasminogen activator because of the unavailabil-
ity of other agents4,5; however, the application of thrombolysis may
be limited by increased risks of thrombus dislodgment, distal embo-
lization,1 and hemorrhagic complications.3
Rapid infusion of thrombolytic agents has also been associated
with higher complication rates.4,5 By determining the lowest effec-
tive infusion dosage, the infusion rate and duration can be set to
minimize risks of thromboembolism and hemorrhage. To our
knowledge, there are no data on the lowest effective dosing regimen
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options, especially in the setting of significant valve disease.
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for specific patient subsets. It is likely that patients who are hemody-
namically unstable require rapid lysis, and current recommended
protocols3 are indicated. For patients who are hemodynamically sta-
ble, however, a slower rate of infusion may be warranted. We pres-
ent a case of prosthetic valve thrombosis successfully treated with
a low-dose regimen of recombinant tissue-type plasminogen activa-
tor (rtPA, 1 mg/h without bolus), such as is typically used for periph-
eral artery bypass graft occlusions. Such an approach for treatment
of prosthetic valve thrombosis has not been reported previously.
Clinical Summary
A 55-year-old woman with a mechanical aortic valve prosthesis (St
Jude 19 mm; St Jude Medical Inc, Minneapolis, Minn) was seen for
two days of exertional chest pain associated with nausea and diapho-
resis. Two weeks before her admission, without seeking medical ad-
vice, the patient discontinued her warfarin sodium therapy. Physical
examination revealed normal vital signs. Results of cardiopulmo-
nary examination were unremarkable except for muffled aortic pros-
thetic valve sounds. Electrocardiography revealed normal sinus
rhythm and left ventricular hypertrophy with strain.
Transthoracic echocardiography suggested restricted motion of
aortic prosthetic leaflets, with turbulent flow on color flow Doppler
scan. Continuous-waveDoppler echocardiography confirmed severe
obstruction, with peak andmean gradients of 158mmHg and 86mm
Hg, respectively (Figure 1, A). There was mild aortic insufficiency.
No obvious thrombus was seen. The left ventricle was normal in
size, with normal systolic function and normal wall thickness. Fluo-
roscopy revealed decreased excursion of both aortic prosthetic leaf-
lets (Figure 2, A;Video 1). The patient was admitted to the coronary
care unit. Because of the patient’s relative hemodynamic stability
and the risk of reoperation, a trial of thrombolysis was elected.
Both streptokinase and urokinase were unavailable at our institution
and other nearby hospitals. We therefore chose a regimen of rtPA to
achieve gradual lysis at the lowest effective dose and thus minimize
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